Hydrogen sulfide and vascular relaxation

Chinese Medical Journal

Volumn 124, Issue 22, 2011, Pages 3816-3819

  Sun, Yan ^a   Tang, Chao Shu ^a,b   Du, Jun Bao ^a,b   Jin, Hong Fang ^a,b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Cardiovascular system; Hydrogen sulfide; Vasorelaxing effects

Indexed keywords

CYCLIC AMP; HYDROGEN SULFIDE; NITRIC OXIDE; POTASSIUM CHANNEL;

ACIDIFICATION; ARTERY; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CONCENTRATION RESPONSE; DOWN REGULATION; HUMAN; INFORMATION RETRIEVAL; MEDLINE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PULMONARY ARTERY; REVIEW; SMOOTH MUSCLE FIBER; SPECIES; TISSUE TYPES; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CARDIOVASCULAR SYSTEM; HUMANS; HYDROGEN SULFIDE; VASODILATION;

EID: 82255169018     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.22.038     Document Type: Review

References (50)

1. Chen CQ, Xin H, Zhu YZ. Hydrogen sulfide: third gaseous transmitter, but with great pharmacological potential. Acta Pharmacol Sin 2007; 28: 1709-1716.
2. Hart JL. Role of sulfur-containing gaseous substances in the cardiovascular system. Front Biosci (Elite Ed) 2011; 3: 736-749.
3. Miller TW, Isenberg JS, Roberts DD. Molecular regulation of tumor angiogenesis and perfusion via redox signaling. Chem Rev 2009; 109: 3099-3124.
4. Walford G, Loscalzo J. Nitric oxide in vascular biology. J Thromb Haemost 2003; 1: 2112-2118.
5. Kajimura M, Fukuda R, Bateman RM, Yamamoto T, Suematsu M. Interactions of multiple gas-transducing systems: hallmarks and uncertainties of CO, NO, and H2S gas biology. Antioxid Redox Signal 2010; 13: 157-192.
6. Baskar R, Bian J. Hydrogen sulfide gas has cell growth regulatory role. Eur J Pharmacol 2011; 656: 5-9.
7. Lim JJ, Liu YH, Khin ES, Bian JS. Vasoconstrictive effect of hydrogen sulfide involves downregulation of cAMP in vascular smooth muscle cells. Am J Physiol Cell Physiol 2008; 295: 1261-1270.
8. Tang C, Li XH, Du JB. Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system. Curr Vasc Pharmacol 2006; 4: 17-22.
9. Kabil O, Banerjee R. Redox biochemistry of hydrogen sulfide. J Biol Chem 2010; 285: 21903-21907.
10. Alexander SP, Mathie A, Peters JA. Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol 2008; 153 Suppl 2: S1-209.
11. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, et al. H2S as a Physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008; 322: 587-590.
12. Eto K. Ogasawara M, Umemura K, Nagai Y, Kimura H. Hydrogen sulfide is produced in response to neuronal excitation. J Neurosci 2002; 22: 3386-3391.
13. Łowicka E, Bełtowski J. Hydrogen sulfide (H2S)-the third gas of interest for pharmacologists. Pharmacol Rep 2007; 59: 4-24.
14. Shibuya N, Mikami Y, Kimura Y, Nagahara N, Kimura H. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem 2009; 146: 623-626.
15. Sun Y, Tang CS, Jin HF, Du JB. The vasorelaxing effect of hydrogen sulfide on isolated rat aortic rings versus pulmonary artery rings. Acta Pharmacol Sin 2011; 32: 456-464.
16. Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 2001; 20: 6008-6016.
17. Ali MY, Ping CY, Mok YY, Ling L, Whiteman M, Bhatia M, et al. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol 2006; 149: 625-634.
18. Olson KR, Dombkowski RA, Russell MJ, Doellman MM, Head SK, Whitfield NL, et al. Hydrogen sulfide as an oxygen sensor/transducer in vertebrate hypoxic vasoconstriction and hypoxic vasodilation. J Exp Biol 2006; 209: 4011-4023.
19. Olson KR, Whitfield NL, Bearden SE, St Leger J, Nilson E, Gao Y, et al. Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen sulfide mechanism. Am J Physiol Regul Integr Comp Physiol 2010; 298: R51-R60.
20. Łowicka E, Bełtowski J. Hydrogen sulfide (H2S)-the third gas of interest for pharmacologists. Pharmacol Rep 2007; 59: 4-24.
21. Szabó C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007; 6: 917-935.
22. Shibuya N, Mikami Y, Kimura Y, Nagahara N, Kimura H. Vascular endothelium expresses 3-mercaptopyruvate sulfur-transferase and produces hydrogen sulfide. J Biochem 2009; 146: 623-626.
23. Prabha M, Jin HF, Tian Y, Tang CS, DU JB. Mechanisms responsible for pulmonary hypertension. Chin Med J 2008; 121: 2604-2609.
24. Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM. Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 2001; 88: 2-11.
25. Zhu P, Huang L, Ge X, Yan F, Wu R, Ao Q. Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling. Int J Exp Pathol 2006; 87: 463-474.
26. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, et al. H2S as a Physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008; 322: 587-590.
27. Wang YF, Mainali P, Tang CS, Shi L, Zhang CY, Yan H, et al. Effects of nitric oxide and hydrogen sulfide on the relaxation of pulmonary arteries in rats. Chin Med J 2008; 121: 420-423.
28. Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y, et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 2004; 318: 756-763.
29. Geng B, Yang J, Qi Y, Zhao J, Pang Y, Du J, et al. H2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 2004; 313: 362-368.
30. Chen YH, Wu R, Geng B, Qi YF, Wang PP, Yao WZ, et al. Endogenous hydrogen sulfide reduces airway inflammation and remodeling in a rat model of asthma. Cytokine 2009; 45: 117-123.
31. Su YW, Liang C, Jin HF, Tang XY, Han W, Chai LJ, et al. Hydrogen sulfide regulates cardiac function and structure in adriamycin-induced cardiomyopathy. Circ J 2009; 73: 741-749.
32. Li L, Hsu A, Moore PK. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation-a tale of three gases. Pharmacol Ther 2009; 123: 386-400.
33. Patacchini R, Santicioli P, Giuliani S, Maggi CA. Pharmacological investigation of hydrogen sulfide (H2S) contractile activity in rat detrusor muscle. Eur J Pharmacol 2005; 509: 171-177.
34. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, et al. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 2009; 105: 365-374.
35. Zhang Z, Huang H, Liu P, Tang C, Wang J. Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening KATP channels. Can J Physiol Pharmacol 2007; 85: 1248-1253.
36. Bliksøen M, Kaljusto ML, Vaage J, Stensløkken KO. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart. Eur J Cardiothorac Surg 2008; 34: 344-349.
37. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A 2007; 104: 15560-15565.
38. Hu Y, Chen X, Pan TT, Neo KL, Lee SW, Khin ES, et al. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Pflugers Arch 2008; 455: 607-616.
39. Zhu XY, Yan XH, Chen SJ. H2S protects myocardium against ischemia/reperfusion injury and its effect on c-Fos protein expression in rats. Acta Physiologica Sinica 2008; 60: 221-227.
40. Yan H, Du J, Tang C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 2004; 313: 22-27.
41. Wang Y, Zhao X, Jin H, Wei H, Li W, Bu D, et al. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2009; 29: 173-179.
42. Chunyu Z, Junbao D, Dingfang B, Hui Y, Xiuying T, Chaoshu T. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 2003; 302: 810-816.
43. Xiaohui L, Junbao D, Lin S, Jian L, Xiuying T, Jianguang Q, et al. Down-regulation of endogenous hydrogen sulfide pathway in pulmonary hypertension and pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Circ J 2005; 69: 1418-1424.
44. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997; 237: 527-531.
45. Fujita A, Kurachi Y. Molecular aspects of ATP-sensitive K+ channels in the cardiovascular system and K+ channel openers. Pharmacol Ther 2000; 85: 39-53.
46. Kane GC, Liu XK, Yamada S, Olson TM, Terzic A. Cardiac KATP channels in health and disease. J Mol Cell Cardiol 2005; 38: 937-943.
47. Cao K, Tang GH, Hu DH, Wang R. Molecular basis of ATP-sensitive K+ channels in rat vascular smooth muscles. Biochem Biophys Res Commun 2002; 296: 463-469.
48. Lee SW, Cheng Y, Moore PK, Bian JS. Hydrogen sulphide regulates intracellular pH in vascular smooth muscle cells. Biochem Biophys Res Commun 2007; 358: 1142-1147.
49. Liu YH, Yan CD, Bian JS. Hydrogen sulfide: a novel signaling molecule in the vascular system. J Cardiovasc Pharmacol 2011; Epub ahead of print.
50. Martelli A, Testai L, Breschi MC, Blandizzi C, Virdis A, Taddei S, et al. Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev 2010; Epub ahead of print.